US Stock MarketDetailed Quotes

BLRX BioLine Rx

Watchlist
  • 0.426
  • +0.016+3.88%
Close Nov 1 16:00 ET
  • 0.397
  • -0.029-6.78%
Post 20:01 ET
34.06MMarket Cap-940P/E (TTM)

About BioLine Rx Company

BioLineRx Ltd. is a clinical stage biopharmaceutical company, which engages in the research and development of treatments that focus on cancer. Its product pipeline includes Motaxafortide (BL-8040), which is used for stem-cell mobilization, solid tumors, and acute myeloid lukemia; and AGI-134, which is an immunotherapy treatment used for multiple solid tumors. The company was founded in 2003 and is headquartered in Modi'in, Israel.

Company Profile

SymbolBLRX
Company NameBioLine Rx
Listing DateJul 25, 2011
Founded2003
CEOMr. Philip A. Serlin, C.P.A.,M.B.A.
MarketNASDAQ
Employees79
Securities TypeDR
ADS Ratio1.0 : 15.0
Fiscal Year Ends12-31
AddressModi'in Technology Park,2 HaMa'ayan Street
CityModi'in
ProvinceHaMerkaz
CountryIsrael
Zip Code7177871
Phone972-8-642-9100
Websitehttp://www.biolinerx.com

Company Executives

  • Name
  • Position
  • Salary
  • Philip A. Serlin, C.P.A.,M.B.A.
  • Chief Executive Officer
  • 952.00K
  • Mali Zeevi, C.P.A.
  • Chief Financial Officer
  • 443.00K
  • Dr. Ella Sorani, PhD
  • Chief Development Officer
  • 520.00K
  • Dr. Aharon Schwartz,PhD
  • Chairman of the Board
  • --
  • Holly W. May, M.B.A.
  • President, US
  • 1.01M
  • Dr. Shaoyu Yan, PhD
  • Director
  • --
  • Dr. Avraham Molcho, M.D.
  • Independent Director
  • --
  • Dr. Sandra Panem,PhD
  • Independent Director
  • --
  • Gal Cohen
  • Independent Director
  • --
  • Rami Dar, M.B.A.
  • Independent Director
  • --
  • Dr. B. J. Bormann, PhD
  • Independent Director
  • --
  • Dr. Raphael Hofstein, PhD
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data